Figure 5.
EBV DNA response patterns and association with survival outcomes. (A) Plasma EBV DNA clearance status distributed across nodal response groups (CR vs. non-CR), with a higher clearance rate observed in the CR group. (B-E) EBV DNA clearance after IC was associated with better PFS (B), OS (C), LRRFS (D), and DMFS (E) compared to non-clearance. CI, confidence interval; CR, complete response; DMFS, distant metastasis-free survival; EBV, Epstein-Barr virus; HR, hazard ratio; IC, induction chemotherapy; LRRFS, locoregional relapse-free survival; OS, overall survival; PFS, progression-free survival.
